IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
Clinical trial NCT00406367 · COMPLETED
Trial details
- NCT number
- NCT00406367
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2008-04-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.